Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Viatris Reports Launch Of First Bioequivalent Generic Version Of Copaxone 20 mg/mL Once-Daily In Canada

Author: Benzinga Newsdesk | April 15, 2024 07:01am

Posted In: VTRS